Hadassah

Clinical Trial Begins at Hadassah University Medical Center with New Drug to Treat Stroke

Monday, Oct 24 2011

Clinical Trial Begins at Hadassah University Medical Center with New Drug To Treat Stroke. A Phase IIa clinical trial with a medicine to treat ischemic stroke has begun at the Hadassah University Medical Center, based on the research of Prof. Abd Al-Roof Higazi, head of the Department of Clinical Biochemistry at Hadassah Hospital Ein-Kerem.

The safety and clinical effectiveness of THR-18, a product of Thrombotech, will be tested on patients with ischemic stroke in seven medical centers throughout Europe, India, and Israel. Thrombotech Technologies Ltd. is a Portfolio Company of Clal Biotechnology Industries Ltd., Israel's largest active life sciences investment company, and Hadasit Bio-Holdings Ltd., a publicly traded subsidiary of Hadasit, Hadassah's technology transfer company, with biotech products all based on intellectual property developed and owned by the Hadassah University Medical Center.

Approximately 25 patients will be divided into three groups. One group will receive the currently used medication for treating ischemic stroke--tPA--and the other two groups will be treated with THR-18, in two different doses, in combination with tPA. Plans are for an evaluation of the trial to be completed within a year.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Hospital Mount Scopus Hosts Conference to Mark Annual World Down Syndrome Day

Hadassah Hospital Mount Scopus hosted 200 people at the annual World Down Syndrome Day conference, held at the hospital in late March.

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Physicians Increase Number of Partial Thyroidectomies Following New ATA Guidelines

Following updated recommendations from the American Thyroid Association (ATA), Nir Hirschoren, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More